We subsequently generated orthotopic xenografts to evaluate tumorigenicity using these same pretreated GPC lines where, as expected, dual inhibition of STAT3 and IGF-1R conferred the greatest survival benefit and extended tumor latency in the STAT3-low group of mice (Fig. 4g, h). This evidence concerns the gene STAT3 and neoplasm.